Market Tracker

08/22 5:16pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

85.80
Delayed Data
As of 4:00pm ET
 +1.12 / +1.32%
Today’s Change
31.38
Today|||52-Week Range
86.92
+129.17%
Year-to-Date

Today’s Trading

Previous close84.68
Today’s open84.83
Day’s range83.51 - 86.01
Volume538,587
Average volume (3 months)965,049
Market cap$7.8B
Dividend yield--
Data as of 4:00pm ET, 08/22/2017

Growth & Valuation

Earnings growth (last year)-38.84%
Earnings growth (this year)-9.60%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+14.75%
P/E ratioNM
Price/Sales67.96
Price/Book7.91

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc-0.63-1.24%
JAZZJazz Pharmaceuticals...+4.12+2.89%
SGENSeattle Genetics Inc+1.30+2.81%
TSROTESARO Inc+1.76+1.48%
Data as of 4:00pm ET, 08/22/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$1.27
Annual revenue (last year)$47.2M
Annual profit (last year)-$410.1M
Net profit margin-869.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts